Prosight Management’s Cognition Therapeutics CGTX Stock Holding History

Prosight Management’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-120,198	Closed	-$254K	–	39
2022 Q2	$254K	Sell	120,198 -119,882	-50%	-$310K	0.21%	24
2022 Q1	$660K	Sell	240,080 -61,899	-20%	-$239K	0.46%	28
2021 Q4	$1.91M	Buy	+301,979	New	+$2.94M	1.27%	23

Other funds holding CGTX

Pathstone Family Office Englewood, New Jersey $12.8B AUM 21.02% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Voss Capital Houston, Texas $1.75B AUM 1.03% 1-Year Est. Return

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Carlson Capital Dallas, Texas $253M AUM 27.64% 1-Year Est. Return

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return